DE602005022093D1 - Bewertungsverfahren zum bestimmen der eignung des pankreas zur inselisolierung - Google Patents

Bewertungsverfahren zum bestimmen der eignung des pankreas zur inselisolierung

Info

Publication number
DE602005022093D1
DE602005022093D1 DE602005022093T DE602005022093T DE602005022093D1 DE 602005022093 D1 DE602005022093 D1 DE 602005022093D1 DE 602005022093 T DE602005022093 T DE 602005022093T DE 602005022093 T DE602005022093 T DE 602005022093T DE 602005022093 D1 DE602005022093 D1 DE 602005022093D1
Authority
DE
Germany
Prior art keywords
pancreas
insel
suitability
insulation
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005022093T
Other languages
English (en)
Inventor
Lawrence Gazda
Albert L Rubin
Barry Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rogosin Institute Inc
Original Assignee
Rogosin Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Institute Inc filed Critical Rogosin Institute Inc
Publication of DE602005022093D1 publication Critical patent/DE602005022093D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602005022093T 2004-11-17 2005-11-14 Bewertungsverfahren zum bestimmen der eignung des pankreas zur inselisolierung Active DE602005022093D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62922704P 2004-11-17 2004-11-17
PCT/US2005/041219 WO2006055501A2 (en) 2004-11-17 2005-11-14 Scoring method for determining pancreas suitability for islet isolation

Publications (1)

Publication Number Publication Date
DE602005022093D1 true DE602005022093D1 (de) 2010-08-12

Family

ID=36407670

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005022093T Active DE602005022093D1 (de) 2004-11-17 2005-11-14 Bewertungsverfahren zum bestimmen der eignung des pankreas zur inselisolierung

Country Status (18)

Country Link
US (1) US7413871B2 (de)
JP (1) JP4704439B2 (de)
KR (1) KR100890375B1 (de)
CN (1) CN101056988B (de)
AT (1) ATE472608T1 (de)
AU (1) AU2005306676B2 (de)
CA (1) CA2587695C (de)
DE (1) DE602005022093D1 (de)
DK (1) DK1812583T3 (de)
ES (1) ES2344796T3 (de)
HK (1) HK1104324A1 (de)
HR (1) HRP20100472T1 (de)
IL (1) IL182853A0 (de)
NZ (1) NZ554964A (de)
PT (1) PT1812583E (de)
RS (1) RS51392B (de)
RU (1) RU2355404C2 (de)
WO (1) WO2006055501A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE547004T1 (de) * 2005-09-26 2012-03-15 Rogosin Inst Inc Sekretionszellenhaltige macrobeads, die seakem- gold-agarose enthalten, und ihre verwendungen
CN117063921A (zh) * 2023-10-17 2023-11-17 成都中科奥格生物科技有限公司 一种胰腺保存液及其制备方法和胰腺保存方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395821T3 (es) * 2000-01-19 2013-02-15 University Of North Carolina At Chapel Hill Fuente de tejido de hígado

Also Published As

Publication number Publication date
RU2355404C2 (ru) 2009-05-20
AU2005306676A2 (en) 2006-05-26
US20060121445A1 (en) 2006-06-08
RS51392B (en) 2011-02-28
HRP20100472T1 (hr) 2010-10-31
NZ554964A (en) 2008-11-28
KR100890375B1 (ko) 2009-03-25
ES2344796T3 (es) 2010-09-07
US7413871B2 (en) 2008-08-19
DK1812583T3 (da) 2010-08-02
CN101056988B (zh) 2011-06-15
AU2005306676A1 (en) 2006-05-26
KR20070084295A (ko) 2007-08-24
CN101056988A (zh) 2007-10-17
CA2587695C (en) 2014-07-15
PT1812583E (pt) 2010-10-12
ATE472608T1 (de) 2010-07-15
RU2007122628A (ru) 2008-12-27
AU2005306676B2 (en) 2010-02-11
HK1104324A1 (en) 2008-01-11
JP2008520240A (ja) 2008-06-19
CA2587695A1 (en) 2006-05-26
IL182853A0 (en) 2007-08-19
WO2006055501A2 (en) 2006-05-26
JP4704439B2 (ja) 2011-06-15
WO2006055501A3 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
DE602006005396D1 (de) Dachpappezusammensetzung
WO2017070256A3 (en) Method for screening inhibitors of ras
EA200900933A1 (ru) Детектирование событий получения трансгенных растений
WO2007130646A3 (en) Hcv coreceptor and methods of use thereof
MX2007002908A (es) Sondas inmovilizadas y metodos para detectar proteinas prionicas alteradas conformacionalmente.
ATE497492T1 (de) Reinigung von montelukast
BRPI0608505B8 (pt) comprimido sublingual revestido
GB0617429D0 (en) Markers of renal transplant rejection and renal damage
DE602004030372D1 (de) Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
EA200970136A1 (ru) Способ выращивания растений
MA33210B1 (fr) Nouveaux anticorps anti-a5b1 et leurs utilisations
DE602007012836D1 (de) Cd86- und cd80-rezeptorkonkurrenztests
DE602005026855D1 (de) Vorrichtungen und verfahren zur bestimmung von proteaseaktivität
MX2008013397A (es) Analisis de perfilamiento de expresion diferencial de fenotipos de cultivo celular y usos de los mismos.
RS54451B1 (en) TOLL-LIKE RECEPTOR ANTAGONISTS 3
ATE458196T1 (de) Verfahren zum apoptosenachweis
ATE529571T1 (de) Verfahren und vorrichtung zum erfassen des zustands von linienbauwerken
DE602005022093D1 (de) Bewertungsverfahren zum bestimmen der eignung des pankreas zur inselisolierung
NO20080216L (no) Fremgangsmater for a bestemme farmakokinetikk til malsokte terapier
MX2007000043A (es) Metodos para la determinacion de la potencia, especificidad y toxicidad de prostaglandina d2 sintasa hematopoyetica.
ATE452146T1 (de) Sporenspezifische antikörper
DE502006005680D1 (de) Vorrichtung zum küstenschutz
WO2007117569A3 (en) Methods of determining skeletal maturity